Journals / Haseki Tıp Bülteni / 2014 / Cilt: 52 - Sayı: 3

A Case of Systemic Lupus Erythematosus Confused with Infective Endocarditis

İnfektif Endokarditle Karışan Sistemik Lupus Eritematozus Olgusu

Pages
212–215
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we present a case of SLE that was confused with infective endocarditis (IE) due to the presence of high fever associated with autoimmune hemolytic anemia (AHA) and proteinuria as well as increased erythrocyte sedimentation rate (ESR), cardiac murmur, and Roth's spots.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease resulting from immune system-mediated tissue damage.
📊
Key Findings & Data:Hemolytic anemia, skin lesions, arthralgia, arthritis, decreased complement levels, and autoantibody positivity, including antinuclear autoantibody (ANA), positivity can be seen.
💡
Conclusion & Impact:Here, we present a case of SLE that was confused with infective endocarditis (IE) due to the presence of high fever associated with autoimmune hemolytic anemia (AHA) and proteinuria as well as increased erythrocyte sedimentation rate (ESR), cardiac murmur, and Roth's spots.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease resulting from immune system-mediated tissue damage. Clinical findings of SLE can involve skin, kidney, central nervous system, cardiovascular system, serosal membranes, and the hematologic and immune systems. In the differential diagnosis, other connective tissue diseases, infective endocarditis, infections such as viral hepatitis, endocrine disorders such as hypothyroidism, sarcoidosis, and some malignant tumors should be considered. Infective endocarditis can imitate all the symptoms of SLE depending on immune complex accumulation glomerulonephritis. Hemolytic anemia, skin lesions, arthralgia, arthritis, decreased complement levels, and autoantibody positivity, including antinuclear autoantibody (ANA), positivity can be seen. Therefore, high fever, blood cultures, eye examination, and echocardiographic findings are of particular value. Here, we present a case of SLE that was confused with infective endocarditis (IE) due to the presence of high fever associated with autoimmune hemolytic anemia (AHA) and proteinuria as well as increased erythrocyte sedimentation rate (ESR), cardiac murmur, and Roth's spots.

Özet

Sistemik lupus eritematozus (SLE); immün sistem aracılı doku hasarı ile sonuçlanan multisistemik otoimmün bir hastalıktır. SLE'nin klinik bulguları cilt, eklem, böbrek, santral sinir sistemi, kardiyovasküler sistem, serozal membranlar, hematolojik ve immünolojik sistemler ile ilgili olabilir. Ayırıcı tanıda; bağ dokusu hastalıkları, infektif endokardit, viral hepatitler gibi enfeksiyonlar, hipotiroidi gibi endokrin hastalıklar, sarkoidoz ve bazı malign tümörler mutlaka gözden geçirilmelidir. İnfektif endokardit immün kompleks birikimine bağlı olarak SLE'nin tüm bulgularını taklit edebilir. Glomerülonefrit, hemolitik anemi, deri bulguları, artraljiartrit, kompleman düşüklüğü ve anti nükleer antikor (ANA) dahil olmak üzere oto antikor pozitifliği görülebilir. Bu nedenle ateş öyküsü, kan kültürleri, göz muayenesi ve özellikle ekokardiyografi (EKO) bulguları çok değerlidir. Burada otoimmün hemolitik anemi (OHA) ve proteinüri ile gelen ateş, eritrosit sedimentasyon hızı (ESH) yüksekliği, kardiyak üfürüm ve roth lekeleri nedeniyle infektif endokarditle (İE) karışan SLE olgusunu sunduk.

🔖

Cite This Article

SERİN, S., KUTLU, K. T., SALER, T. (2014). A Case of Systemic Lupus Erythematosus Confused with Infective Endocarditis. Haseki Tıp Bülteni, Cilt: 52 - Sayı: 3, 212–215. https://ajindex.com/articles/267916

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008;358:929-39.
  2. Pons-Estel GJ, Alarcón GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin arthritis Rheum 2010; 39:257-68.
  3. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006;15:308-18.
  4. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 2000;124:71-81.
  5. Ippolito A, Wallace DJ, Gladman D, et al. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus 2011;20:250-5.
  6. Özgüler Y, Melikoğlu M. Sistemik Lupus Eritematozus: Klinik Bulgulara Genel Bakış. Turkiye Klinikleri Journal of Rheumatology Special Topics 2011;4:1-10.
  7. Boumpas DT, Austin HA 3rd, Fessler BJ, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 1995;122:940-50.
  8. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8. Prendergast BD. Diagnostic criteria and problems in infective endocarditis. Heart 2004;90:611-3.
  9. Moreillon P, Que YA. Infective endocarditis. Lancet 2004;363:139-49. Habib G. Management of infective endocarditis. Heart 2006;92:124-30.
  10. Kokori SI, Ioannidis JP, Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. Am J Med 2000;108:198-204.
  11. Feldman M, Aziz B, Kang GN, Opondo MA, Belz RK, Sellers C. C-reactive protein and erythrocyte sedimentation rate discordance: frequency and causes in adults. Transl Res 2013; 161:37-43.
  12. Roman MJ, Salmon JE. Cardiovascular manifestations of rheumatologic diseases. Circulation 2007;116:2346-55.